Recall of FREESTYLE BLOOD GLUCOSE MONITORING SYSTEM

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ABBOTT LABORATORIES LIMITED. DIAGNOSTIC DIVISION.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    105256
  • Event Risk Class
    II
  • Event Initiated Date
    2014-02-21
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Abbott has identified through internal testing and investigation that all non-applied voltage legacy meters (here after referred to as 0mv meters) have the potential to produce out of range control solution results and/or erroneously low blood glucose results when used in conjunction with freestyle test strip lot within expiry. this issue only occurs when freestyle and freestyle lite strips are used with the freestyle blood glucose meter the freestyle mini blood glucose meter and the freestyle blood glucose meter built into the omnipod insulin management system (or 0mv meters).

Device

  • Model / Serial
    Model Catalog: 81017 (Lot serial: ALL LOTS); Model Catalog: 80000 (Lot serial: ALL LOTS); Model Catalog: 11001 (Lot serial: ALL LOTS)
  • Product Description
    FREESTYLE BLOOD GLUCOSE MONITORING SYSTEM
  • Manufacturer

Manufacturer

  • Manufacturer Address
    MISSISSAUGA
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    HC